ResearchGate Restricts Access to Nearly 2 Million Articles

The academic social network is bending to pressure from publishing giants that demand it removes copyrighted material from its site.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, PERE_RUBIClarification (November 10): The 1.7 million figure cited in this article was first published on Twitter on November 1 by Nature's Richard Van Noorden following a phone conversation with CRS spokesman James Milne. This figure was also cited by Nature on November 8.

The academic social network ResearchGate has taken moves to restrict access to at least 1.7 million scholarly articles following threats of legal action by a coalition of publishers including Elsevier and the American Chemical Society (ACS), Times Higher Education reports today (November 9). The change, which follows months of conflict between the organizations, means that papers once freely available to download now have to be requested directly from their authors.

“ResearchGate’s primary service is taking high-quality content written and published by others and making as many as 7 million copyrighted articles—40% of its total content—freely available via its for-profit platform,” the Coalition for Responsible Sharing, a collaboration formed between ACS, Brill, Elsevier, Wiley, and Wolters Kluwer, writes in a statement published on October 5. “Numerous attempts to agree with ResearchGate on amicable solutions . . . remained unsuccessful. Members of the Coalition for Responsible Sharing are therefore now resorting to formal means to alter ResearchGate’s damaging practices.”

On October 6, two of the Coalition’s members—Elsevier and ACS—filed a lawsuit in Germany to prevent the Berlin-based paper-sharing site from hosting copyrighted material in the future. Around the same time, an initial batch of “take-down notices” was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio